Free Trial Information
BioCentury | Apr 15, 2013
Company News

Gliatech, Janssen Pharmaceutica N.V. deal

...in preclinical testing, that retard the progression of Alzheimer's disease by acting on glial cells. Gliatech Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Gliatech board of directors update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound Appointed: Ronald Henriksen, CEO of Itasca Ventures LLC WIR Staff...
Read More
BioCentury | Apr 15, 2013
Clinical News

Gliatech regulatory update

...post-surgical scarring and adhesion. GLIA submitted a PMA to the FDA for Adcon-L in December. Gliatech Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Gliatech management update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound, Neurological Promoted: Kurt Brunden, Ph.D., vice president of research; formerly head of biomolecular and chemical research. WIR Staff Dermatology Neurology...
Read More
BioCentury | Apr 15, 2013
Clinical News

Gliatech regulatory update

...see BioCentury, Part I). The FDA accepted GLIA's PMA filing for Adcon-L in February 1997. Gliatech Inc....
Read More
BioCentury | Mar 17, 2003
Company News

Gliatech, Solentix BioSciences Inc. deal

...to develop anti-properdin antibodies. Solentix said this deal would be included in the asset acquisition. Gliatech Inc....
Read More
BioCentury | Jan 13, 2003
Company News

Gliatech, Wright Medical deal

...The sale is part of GLIA’s previously announced bankruptcy proceedings (see BioCentury, May 6, 2002). Gliatech Inc....
Read More
BioCentury | Oct 28, 2002
Company News

Aastrom management update

...Hired: Robert Bard as VP of regulatory affairs and quality systems, formerly a VP at Gliatech Inc. WIR...
Read More
BioCentury | May 6, 2002
Clinical News

Adcon-L bioresorbable barrier gel regulatory update

...in cash as of March 31, which the company said will fund operations through May. Gliatech Inc....
Read More
BioCentury | Jan 22, 2002
Company News

Gliatech board of directors update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound Resigned: William Clarke and Allan Green WIR Staff Dermatology...
Read More
Items per page:
1 - 10 of 156
BioCentury | Apr 15, 2013
Company News

Gliatech, Janssen Pharmaceutica N.V. deal

...in preclinical testing, that retard the progression of Alzheimer's disease by acting on glial cells. Gliatech Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Gliatech board of directors update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound Appointed: Ronald Henriksen, CEO of Itasca Ventures LLC WIR Staff...
Read More
BioCentury | Apr 15, 2013
Clinical News

Gliatech regulatory update

...post-surgical scarring and adhesion. GLIA submitted a PMA to the FDA for Adcon-L in December. Gliatech Inc....
Read More
BioCentury | Apr 15, 2013
Company News

Gliatech management update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound, Neurological Promoted: Kurt Brunden, Ph.D., vice president of research; formerly head of biomolecular and chemical research. WIR Staff Dermatology Neurology...
Read More
BioCentury | Apr 15, 2013
Clinical News

Gliatech regulatory update

...see BioCentury, Part I). The FDA accepted GLIA's PMA filing for Adcon-L in February 1997. Gliatech Inc....
Read More
BioCentury | Mar 17, 2003
Company News

Gliatech, Solentix BioSciences Inc. deal

...to develop anti-properdin antibodies. Solentix said this deal would be included in the asset acquisition. Gliatech Inc....
Read More
BioCentury | Jan 13, 2003
Company News

Gliatech, Wright Medical deal

...The sale is part of GLIA’s previously announced bankruptcy proceedings (see BioCentury, May 6, 2002). Gliatech Inc....
Read More
BioCentury | Oct 28, 2002
Company News

Aastrom management update

...Hired: Robert Bard as VP of regulatory affairs and quality systems, formerly a VP at Gliatech Inc. WIR...
Read More
BioCentury | May 6, 2002
Clinical News

Adcon-L bioresorbable barrier gel regulatory update

...in cash as of March 31, which the company said will fund operations through May. Gliatech Inc....
Read More
BioCentury | Jan 22, 2002
Company News

Gliatech board of directors update

Gliatech Inc. (GLIA), Cleveland, Ohio Business: Biomaterial/Skin/Wound Resigned: William Clarke and Allan Green WIR Staff Dermatology...
Read More
Items per page:
1 - 10 of 156